首页|西地那非致药物性肝损伤的文献分析

西地那非致药物性肝损伤的文献分析

扫码查看
目的:通过分析西地那非致药物性肝损伤(DILI)的病例报道,探讨DILI的特点,为西地那非导致DILI的不良反应提供依据.方法:检索国内外西地那非导致DILI的病例报道,对病例中患者的药物治疗、DILI情况、治疗措施及转归等进行分析,比较国内外西地那非导致DILI处理措施的异同并探讨西地那非致DILI的作用机制.结果:本文共检索到国内外相关报道6例;6例均为男性,服用西地那非剂量为25~100 mg;6例服用西地那非致DILI的时间差异较大;4例临床症状表现为皮肤黄染,肝内成胆汁淤积;3例受损类型为胆汁淤积型;3例DILI极可能由西地那非导致,3例很可能由西地那非导致;4例为重度肝损伤;2例为轻度肝损伤;6例停用西地那非后,肝功能均可逐渐恢复或正常.结论:西地那非导致DILI鲜有报道,作用机制尚不完全明确,可能与其改变肝脏组织有关,建议长期或较大剂量服用西地那非的患者注意监测肝功能.
Analysis of liver injury induced by sildenafil
Objective:To analyze the reports of drug-induced liver injury(DILI)induced by sildenafil,explore the characteristics of DILI,and provide evidence for the liver damage of sildenafil.Methods:The relevant literature at home and abroad were reviewed.Medications,DILI,treatments and outcomes of the patients were analyzed.The difference between home and abroad in treatments of DILI was compared.The mechanisms of sildenafil-induced DILI were studied.Results:A total of 6 cases were reported and all patients were male.The dosage of sildenafil was 25 mg to 100 mg.The duration of sildenafil-induced DILI was significantly different among the 6 patients.The clinical symptoms of 4 patients were jaundice and intrahepatic cholestasis.The 6 patients included 3 cholestatic liver damage,4 of severe degree and 2 of mild degree.DILI was highly probably caused by sildenafil in 3 patients and probably in another 3 patients.After the onset of DILI,the patients discontinued sildenafil,and all of 6 patients were recovered and 2 of them were given liver-protecting drugs.Conclusion:Liver injury caused by sildenafil is rarely reported,and the mechanism is non-specific and unclear,which may be related to causing changes of liver tissue.It is recommended to regularly monitor liver function in patients who take sildenafil for a long time or at large dosages.

sildenafildrug-induced liver damagemechanismliver functioncholestasis

曹小雨、葛洁、王婧雯、杨瑞霞、王莹

展开 >

西安医学院第二附属学院临床药学科,西安 710038

空军军医大学第一附属医院药剂科,西安 710032

三原县人民医院药剂科,咸阳 713800

西地那非 药物性肝损伤 机制 肝功能 胆汁淤积

国家自然科学基金

72074218

2024

中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
年,卷(期):2024.33(6)
  • 18